Scalable detection of technically challenging variants through modified next‐generation sequencing

Abstract

NGS assays can detect technically challenging variants when chemistries and bioinformatics are jointly refined. The adaptations described support a scalable, cost-effective path to identifying all clinically relevant variants within a single sample.